Clinical Trial

Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis

Study acronym: RESCUE UC
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to examine patients with acute severe UC who are refractory to intravenous corticosteroids and determine whether a strategy of using upadacitinib first followed by infliximab in upadacitinib non-responders is non-inferior to conventional management with infliximab only.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-25.
Status change: Not Yet Recruiting → Recruiting 2025-06-17
Trial Details
NCT Number NCT06660693
Lead Sponsor McMaster University
Collaborators: AbbVie
Conditions Colitis, Ulcerative
Enrollment 134 participants
Start Date 2025-04-16
Primary Completion 2027-05 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-06-22